Franklin Resources’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $171K | Buy |
|
|||||
|
2024
Q4 | $35.2K | Hold |
|
|||||
|
2024
Q3 | $41.2K | Sell |
|
|||||
|
2024
Q2 | $22.1M | Sell |
|
|||||
|
2024
Q1 | $17.7M | Sell |
|
|||||
|
2023
Q4 | $10.9M | Sell |
|
|||||
|
2023
Q3 | $7.17M | Sell |
|
|||||
|
2023
Q2 | $8.65M | Sell |
|
|||||
|
2023
Q1 | $17.9M | Buy |
|
|||||
|
2022
Q4 | $29.7M | Sell |
|
|||||
|
2022
Q3 | $50.1M | Buy |
|
|||||
|
2022
Q2 | $33M | Sell |
|
|||||
|
2022
Q1 | $67.9M | Sell |
|
|||||
|
2021
Q4 | $109M | Sell |
|
|||||
|
2021
Q3 | $128M | Sell |
|
|||||
|
2021
Q2 | $206M | Buy |
|
|||||
|
2021
Q1 | $205M | Sell |
|
|||||
|
2020
Q4 | $269M | Sell |
|
|||||
|
2020
Q3 | $191M | Buy |
|
|||||
|
2020
Q2 | $216M | Sell |
|
|||||
|
2020
Q1 | $150M | Buy |
|
|||||
|
2019
Q4 | $290M | Buy |
|
|||||
|
2019
Q3 | $191M | Buy |
|
|||||
|
2019
Q2 | $173M | Buy |
|
|||||
|
2019
Q1 | $210M | Buy |
|
|||||
|
2018
Q4 | $218M | Buy |
|
|||||
|
2018
Q3 | $185M | Sell |
|
|||||
|
2018
Q2 | $231M | Sell |
|
|||||
|
2018
Q1 | $194M | Sell |
|
|||||
|
2017
Q4 | $148M | Sell |
|
|||||
|
2017
Q3 | $136M | Buy |
|
|||||
|
2017
Q2 | $116M | Sell |
|
|||||
|
2017
Q1 | $127M | Buy |
|
|||||
|
2016
Q4 | $101M | Sell |
|
|||||
|
2016
Q3 | $133M | Sell |
|
|||||
|
2016
Q2 | $140M | Buy |
|
|||||
|
2016
Q1 | $143M | Buy |
|
|||||
|
2015
Q4 | $157M | Buy |
|
|||||
|
2015
Q3 | $142M | Sell |
|
|||||
|
2015
Q2 | $198M | Buy |
|
|||||
|
2015
Q1 | $72.8M | Buy |
|
|||||
|
2014
Q4 | $44.9M | Buy |
|
|||||
|
2014
Q3 | $35.2M | Buy |
|
|||||
|
2014
Q2 | $45.3M | Buy |
|
|||||
|
2014
Q1 | $45.2M | Buy |
|